Clinical and economic impact of school ‐based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis
ConclusionUniversal two‐dose nonavalent HPV vaccination for 11‐ to 12‐year‐old adolescent women is very cost‐effective in Singapore.
Tweetable abstractNonavalent HPV vaccination of 11‐ to 12‐year‐old girls is cost‐effective in Singapore.
Source: BJOG: An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: SK Tay, T ‐Y Hsu, A Pavelyev, A Walia, AS Kulkarni Tags: Health Economics Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Cytology | Economics | Epidemiology | Gardasil | Genital Warts | Girls | Human Papillomavirus (HPV) | OBGYN | Singapore Health | Vaccines | Warts | Women